Journal of Experimental Therapeutics and Oncology: Impact Factor, Ranking, H-Index, ISSN, CiteScore, SJR and Other Key Journal Metrics | Researcher.Life

All Solutions

Unlock unlimited use of all AI tools with the Editage All Access membership.

Explore Editage All Access

Support

Go to journal finder

Scope & Metrics
Journal Specification
Published Literature
FAQs

Journal of Experimental Therapeutics and Oncology Key Metrics

CiteScore

1.4

H-Index

39

SJR

Q4Pharmacology

SNIP

0.39

Journal of Experimental Therapeutics and Oncology Journal Specifications

Indexed in the following public directories

SJR

Overview
Publisher	OLD CITY PUBLISHING INC
Language	English
Frequency	Semi-annual
General Details
Language	English
Frequency	Semi-annual
Publication Start Year	1996
Publisher URL	Visit website
Website URL	Visit website

View less

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Recently Published Papers in Journal of Experimental Therapeutics and Oncology

Alteration of the fragile histidine triad gene early in carcinogenesis: an update.

1 Nov 2003
Journal of experimental therapeutics & oncology

Clinical applications of DNA microarray analysis.

1 Nov 2003
Journal of experimental therapeutics & oncology

1 Nov 2003
Journal of Experimental Therapeutics and Oncology

Vanadium suppresses sister-chromatid exchange and DNA-protein crosslink formation and restores antioxidant status and hepatocellular architecture during 2-acetylaminofluorene-induced experimental rat hepatocarcinogenesis.

1 Nov 2003
Journal of experimental therapeutics & oncology

Small cell lung cancer: from molecular biology to novel therapeutics.

1 Nov 2003
Journal of experimental therapeutics & oncology

1 Nov 2003
Journal of Experimental Therapeutics and Oncology

Alteration of the fragile histidine triad gene early in carcinogenesis: an update.

1 Nov 2003
Journal of experimental therapeutics & oncology

Clinical applications of DNA microarray analysis.

1 Nov 2003
Journal of experimental therapeutics & oncology

1 Nov 2003
Journal of Experimental Therapeutics and Oncology

Vanadium suppresses sister-chromatid exchange and DNA-protein crosslink formation and restores antioxidant status and hepatocellular architecture during 2-acetylaminofluorene-induced experimental rat hepatocarcinogenesis.

1 Nov 2003
Journal of experimental therapeutics & oncology

Small cell lung cancer: from molecular biology to novel therapeutics.

1 Nov 2003
Journal of experimental therapeutics & oncology

1 Nov 2003
Journal of Experimental Therapeutics and Oncology

View all papers for this journal

FAQs on Journal of Experimental Therapeutics and Oncology

How long has Journal of Experimental Therapeutics and Oncology been actively publishing?

Journal of Experimental Therapeutics and Oncology has been in operation since 1996 till date.

What is the publishing frequency of Journal of Experimental Therapeutics and Oncology?

Journal of Experimental Therapeutics and Oncology published with a Semi-annual frequency.

What is the eISSN & pISSN for Journal of Experimental Therapeutics and Oncology?

For Journal of Experimental Therapeutics and Oncology, eISSN is 1533-869X and pISSN is 1359-4117.

What is Citescore for Journal of Experimental Therapeutics and Oncology?

Citescore for Journal of Experimental Therapeutics and Oncology is 1.4.

What is the H Index for Journal of Experimental Therapeutics and Oncology ?

H Index for Journal of Experimental Therapeutics and Oncology is 39.

What is SNIP score for Journal of Experimental Therapeutics and Oncology?

SNIP score for Journal of Experimental Therapeutics and Oncology is 0.39.

What is the SJR for Journal of Experimental Therapeutics and Oncology?

SJR for Journal of Experimental Therapeutics and Oncology is Q4.

Who is the publisher of Journal of Experimental Therapeutics and Oncology?

OLD CITY PUBLISHING INC is the publisher of Journal of Experimental Therapeutics and Oncology.

Global Journal Library: